Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)
Price and Volume
Detailed Quote| Volume | 368,106 |
| Open | 44.97 |
| Bid (Size) | 43.42 (500) |
| Ask (Size) | 43.48 (100) |
| Prev. Close | 44.96 |
| Today's Range | 43.09 - 45.09 |
| 52wk Range | 18.12 - 45.50 |
| Shares Outstanding | 71,726,685 |
| Dividend Yield | N/A |
Performance
Frequently Asked Questions
Is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares publicly traded?
Yes, Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is publicly traded.
What exchange does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trade on?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
What is the current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 43.47
When was Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares last traded?
The last trade of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares was at 02/04/26 03:34 PM ET
What is the market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 3.12B
How many shares of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares are outstanding?
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.